Skip to Main Content

Author Details

Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
1976
492
120
PMIDPaper TitleJournal TitlePublished Year
36322878Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.Blood Adv2023
37595035Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety.Sci Adv2023
37648862Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.Nature2023
37603347Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.Blood Adv2023
37156098Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.Blood Adv2023
37216223Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.Blood Adv2023
36706355Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.Blood2023
36595453Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells.Blood Adv2023
36890846Editorial: Regulatory T cells in graft versus host disease.Front Immunol2023
36332187Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.Blood2023
34807983GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial.Blood Adv2022
35617682Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease.Blood Adv2022
35475885A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.Blood Adv2022
35349491Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.J Clin Invest2022
35696582Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.Proc Natl Acad Sci U S A2022
35484649Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.Haematologica2022
36189229Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease.Front Immunol2022
35226736BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.Blood2022
35286378Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.Blood2022
35058359Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.Proc Natl Acad Sci U S A2022
34793200Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.J Clin Oncol2022
34670169Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.Transplant Cell Ther2022
33361812Mechanism of EBV inducing anti-tumour immunity and its therapeutic use.Nature2021
33720354Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.Blood2021
33521749Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity.Med2021
33877965National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.Transplant Cell Ther2021
33537026Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation.Front Immunol2021
33753942Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.Nat Immunol2021
33658994Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy.Front Immunol2021
33496734Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.Blood Adv2021
34435483Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformation.Haematologica2021
34522041Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.Nat Immunol2021
34581754Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution.Blood Adv2021
34635486Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses.Cancer Immunol Res2021
34041473NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases.J Transl Autoimmun2021
33283990Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell Disease.N Engl J Med2021
31578466Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation.Bone Marrow Transplant2020
31697815Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.Blood2020
31917843PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation.Blood Adv2020
33384686Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.Front Immunol2020
32938797Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect.Sci Transl Med2020
32882002Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia.Blood Adv2020
32766608Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity.medRxiv2020
32667831Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity.J Clin Oncol2020
32478814A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.Blood2020
32417490T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant2020
32516138Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.J Clin Invest2020
32402162Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.N Engl J Med2020
32374880BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation.Blood Adv2020
32533060Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.Nat Commun2020
  • 1 - 50 of 492

Recommended Authors

Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 8
Laura F Newell
Oregon Health and Science University
Career Start Year 2003
Number of shared co-authors 4
Eneida R Nemecek
Oregon Health Sciences University
Career Start Year 2002
Number of shared co-authors 10
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 2
Xingmin Feng
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 1
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 2
Todd A Fehniger
Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 4
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 11
Matthias Edinger
Regensburg University Hospital
Career Start Year 1994
Number of shared co-authors 4
Claudia Rossig
University Children's Hospital Muenster
Career Start Year 1994
Number of shared co-authors 2
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Sarfraz Memon
Center for Cancer Research, National Cancer Institute.
Career Start Year 1988
Number of shared co-authors 4
Koen van Besien
University Hospitals of Cleveland
Career Start Year 1988
Number of shared co-authors 8
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 2
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 7
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 6
Yoko Kosaka
Oregon Health & Science University
Career Start Year 1984
Number of shared co-authors 1
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 10
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 5
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 2
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 9
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 7
Brian R Smith
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 3
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 1
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 12
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 6
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 7
Neal S Young
National Heart Lung and Blood Institute Division of Intramural Research
Career Start Year 1972
Number of shared co-authors 1
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 3

Collaborators

Donna Neuberg
Co-authored papers 51
Catherine J Wu
Co-authored papers 47
Kenneth C Anderson
Dana Farber Cancer Institute
Co-authored papers 42
Richard M Stone
Dana Farber Cancer Institute
Co-authored papers 19
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers 13
Jonathan S Serody
The University of North Carolina School of Medicine
Co-authored papers 12
Ryan A Flynn
Boston Children's Hospital
Co-authored papers 12
William J Murphy
Co-authored papers 11
Robin Fo??
Sapienza University.
Co-authored papers 9
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 7
Vladimir Brusic
Co-authored papers 6
Christopher J Gibson
Co-authored papers 6
Robert Coleman Lindsley
Co-authored papers 6
David P Steensma
Novartis Institutes for BioMedical Research
Co-authored papers 6
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 6
Nir Hacohen
Broad Institute of MIT and Harvard
Co-authored papers 6
Denis-Claude Roy
Universite de Montreal
Co-authored papers 6
James E Bradner
Co-authored papers 5
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 5
Benjamin L Ebert
Co-authored papers 5
Jean Michon
Institut Curie
Co-authored papers 5
Leslie Lehmann
Dana Farber Cancer Institute/Boston Children's Hospital
Co-authored papers 4
Niall J Lennon
Broad Institute of MIT and Harvard.
Co-authored papers 4
Edgar L Milford
Co-authored papers 4
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 4
Nazmim Bhuiya
Harvard T.H. Chan School of Public Health
Co-authored papers 4
Richard L Stevens
School of Biomedical Sciences and Pharmacy, University of Newcastle
Co-authored papers 4
Robert Gentleman
Center for Computational Biomedicine, Harvard Medical School
Co-authored papers 3
Patrick Y Wen
Co-authored papers 3
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Release 1.2